Leading pharmaceutical giant and one of the most crucial players in the fight against COVID-19, Pfizer, has reportedly announced that it has enrolled several volunteers in initial trials for a new pill, that it hopes could potentially cure COVID-19.
In the past few weeks, Johnson & Johnson’s COVID-19 vaccine has been into headlines over claims of being associated with potential blood clots cases. Speculating this, many countries decided to halt its rollout over concern of public safety. However, after d
The country has by far lost 53,498 lives to the deadly virus, with 1,561,559 confirmed cases
Following reports of unusual blood clots in people inoculated with Johnson & Johnson’s COVID-19 vaccine, South
A real-world study of data conducted in Israel has reportedly found that the South African variant of the coronavirus possesses the ability to break through the immunity shield created by Pfizer-BioNTech Covid-19 vaccine.
The Government of Brazil has reportedly announced that the country has detected its first-ever confirmed case of the South African variant. The new case points towards a fresh new sign of danger for a nation that is already being ravaged by the pandemic and reporting
In a recent move to accelerate the availability of COVID-19 vaccines, all the African Union member states are slated to gain access to nearly 220 million doses of the Johnson & Johnson (J&J) single-dose coronavirus vaccine, with the ability to order an extra 1
The clinical trial includes evaluating tolerability, immunogenicity, and safety of two intramuscular vaccinations for HIV-infected children
U.S. headquartered clinical-stage biopharmaceutical company, Curevo Vaccin
A business lobby group in South Africa has reportedly called on the government to shift the focus of its vaccine program on the elderly as well as the vulnerable, to avoid hospitals being flooded with patients from a third COVID-19 wave.
Throughout Southeast Asia and Africa, several aid groups and governments agencies are joining the World Health Organization’s call for pharmaceutical enterprises to share their respective COVID-19 vaccine patent information in an effort to address the yawning global vaccine shortfall more e